These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5536884)

  • 21. The tolbutamide controversy.
    Compr Ther; 1975 May; 1(1):19-20. PubMed ID: 1222531
    [No Abstract]   [Full Text] [Related]  

  • 22. The oral hypoglycemic controversy. Stay as sweet as you are.
    Gregory DR
    Leg Aspects Med Pract; 1979 Mar; 7(3):16-9. PubMed ID: 106193
    [No Abstract]   [Full Text] [Related]  

  • 23. [Attack after oral antidiabetics].
    Frey H
    Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2097-8. PubMed ID: 5479224
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Oral hypoglycemic drugs.
    Scoville AB
    J Tenn Med Assoc; 1975 Apr; 68(4):319-20. PubMed ID: 1117723
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral diabetic drugs again held hazardous.
    J Tenn Med Assoc; 1975 Apr; 68(4):343. PubMed ID: 1117724
    [No Abstract]   [Full Text] [Related]  

  • 26. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
    JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
    [No Abstract]   [Full Text] [Related]  

  • 27. "Settling the UGDP controversy"?
    Bradley RF; Dolger H; Forsham PH; Seltzer H
    JAMA; 1975 May; 232(8):813-7. PubMed ID: 1091759
    [No Abstract]   [Full Text] [Related]  

  • 28. Decisive factors in the tolbutamide controversy.
    O'Sullivan JB; D'Agostino RB
    JAMA; 1975 May; 232(8):825-9. PubMed ID: 1091761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study.
    Fidel J; Nelken L
    Isr J Med Sci; 1974 Jul; 10(7):702-6. PubMed ID: 4852026
    [No Abstract]   [Full Text] [Related]  

  • 30. Misunderstanding or error? The UGDP report after four years.
    Marigo S; Adezati L; Burnetti P; Pozza G; Robba L; Urbinati G
    Acta Diabetol Lat; 1974; 11(5):357-422. PubMed ID: 4156992
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 32. An historical view of the medical-social aspects of the UGDP.
    Knowles HC
    Trans Am Clin Climatol Assoc; 1977; 88():150-6. PubMed ID: 898533
    [No Abstract]   [Full Text] [Related]  

  • 33. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
    Pirart J
    Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
    [No Abstract]   [Full Text] [Related]  

  • 34. A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide.
    Diabetes; 1976 Dec; 25(12):1129-53. PubMed ID: 992232
    [No Abstract]   [Full Text] [Related]  

  • 35. [Should the prescription of oral antidiabetic drugs be more limited? Results from controlled clinical trials].
    Folling I
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1604-6. PubMed ID: 4769481
    [No Abstract]   [Full Text] [Related]  

  • 36. [Various problems in diabetes: from the symposium of the 18th Congress of the Japanese Association of Medical Sciences].
    Yamada K; Abe M; Yamashita K; Murachi T; Shimada N
    Nihon Ishikai Zasshi; 1971 Aug; 66(3):247-60. PubMed ID: 4398768
    [No Abstract]   [Full Text] [Related]  

  • 37. Comments on the UGDP study.
    Schöffling K
    Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oral antidiabetic drugs].
    Z Allgemeinmed; 1975 Feb; 51(5):235. PubMed ID: 1130116
    [No Abstract]   [Full Text] [Related]  

  • 39. Antidiabetic agents and vascular events.
    Keen H
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():99-105. PubMed ID: 783218
    [No Abstract]   [Full Text] [Related]  

  • 40. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.